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1. INTRODUCTION 
Down syndrome (DS) is the most common genetic condition, associated with intellectual 
disability, an increased risk of concomitant congenital defects, and organic disorders. Despite 
these risk factors, morbidity estimates of DS life expectancy suggest an increase in near future1. 
DS was recognized as a genetic condition only in the 19th century. Escorel described the 
appearance of a child with DS in 1838. Later in 1866 John Langdon Down published 
“Observations on an Ethnic Classification of Idiots”, and used the name mongolism because of 
the facial resemblances to East Asian people2-5. Lejeune, Turpin and Gautier found the third 
chromosome 21 in patients with DS in 1959. 
Starting from the identification of the extra chromosome 21 are initiated in vitro and clinical 
studies in order to understand the correlation with phenotypic traits characteristic of the syndrome 
and to understand the role of this chromosome 
To understand DS, it is crucial both to understand the genomic content of chromosome 21 and 
how the expression levels of these genes are altered by the presence of this third copy.
Only recently,new observations have led to the identification of the long arm of chromosome 21 
as the responsible region for the DS phenotype, the DS critical region (DSCR) . Chromosome 21 
is the smallest chromosome, which may explain the presumed durability of this syndrome over 
the evolution 2. At this moment more than 450 genes have been identified on chromosome 21, 
and genes have been identified specifically related to the DSCR 2,3,5. [6]
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2. PATIENT WITH DOWN SYNDROME
Down syndrome (DS) is the most common chromosomal malformations in newborns. In Europe, 
DS represents 8% of all recorded cases of congenital abnormalities. Worldwide, the overall 
prevalence of DS is 10 per 10,000 live births, although in recent years this figure is increasing. To 
a large extent, the prevalence of DS depends on various socio-cultural variables.(6,21,23)
In fact, these variables are related to factors such as the legality or illegality of abortion in 
different countries, the average  women age  in early pregnancy which results to be very uneven 
in the different countries, as well as the level of accuracy of the pre-natal screening. So probably 
in the Western world the percentage of DS diagnosis has increased thanks to a more precise pre-
natal screening test and also  because the maternal age has risen , however  the percentage of new 
born with Down syndrome is not increased because of  the increased pregnancy interruption.
DS is characterized by several dysmorphic features and delayed psychomotor development. 
Children with DS also have an increased risk of concomitant organic diseases and birth defects 
such as congenital heart disease and gastrointestinal defects, celiac disease and hypothyroidism.
Life expectancy in patients with SD has increased considerably and patients can now reach 50-60 
years of age. The main cause of death is linked to congenital heart problems and secondly for 
respiratory infections. Conversely, cause of death from cancer appears to be lower than non SD 
except for some forms of cancer as leukemia and testicular cancer. Thanks to improved surgical 
techniques has greatly decreased the rate of infant mortality of patients with SD. In the 
Netherlands, the rate of infant mortality in children with DS has fallen from 7.07% in 1992 to 4% 
in 2003 (this is in contrast to the infant mortality rate 0.48% of the target population in the 
Netherlands in 2003)(33) The DS of mortality decline is mainly due to early surgical treatment 
success of CHD and to improve the treatment of congenital anomalies of the gastrointestinal 
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tract. Respiratory infections and neonatal problems are the most serious and frequent problems 
that can affect infants with DS.
 Pre Natal screening and  newborn assessment
There are several types of prenatal screening for the diagnosis of SD with different degree of 
accuracies and invasivenessThe ultrasound between 14 and 24 weeks of gestation is the least 
invasive method. It may be associated with  blood sampling (combined test).Then there are the 
chorionic villus sampling at 11-12 weeks or amniocentesis around 15 weeks.Diagnosis at birth is 
based on clinical observation of the characteristics typical of the syndrome and on  genetic 
examination in order to have the definitive diagnosis .  Thanks to prenatal diagnostic techniques 
often parents are already aware at the time of birth that the child will be affected by SD. If instead 
by mistake or by choice, parents are not aware of his son's illness they should be promptly 
informed by pediatricians and briefed of possible congenital diseases related to the syndrome.
19,26 
Phisycal characteristics 
Individuals with DS may have some or all of the following physical characteristics: microgenia 
(abnormally small chin), oblique eye fissures,  muscle hypotonia , flat nasal bridge, a single 
palmar crease, macroglossia, , short neck, white spots on eye and iris, known as Brushfield spots 
excessive joint laxity, excessive space between the big toe and second toe, and short fingers
The neck is short and squat, chest is  plate and elongated, the abdomen is expanded and pelvis is 
lower and wide.
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 Congenital diseases associated with DS
 DS is often associated with different congenital diseases:
cardiovascular disorders,vision disorders,  ear, nose and throat disorders, respiratory disorders, 
gastrointestinal tract disorders, haemato-oncological and immunological disorders,endocrine 
disorders, orthopedics disorders , urinary disorders, dermatologic problems, sexual development 
and neuro-behavioral disorders.
Cardiovascular disorders
The prevalence of CVD in neonates with DS is about 44–58% worldwide. Atrioventricular septal 
defect (ADS) and ventricular septal defect (VSD) are the most common forms of CHD, 
constituting up to 54% for ASD and to 33% for VSD, of all CVDs in children with DS.31,33
 Other most frequently cardiovascular anomalies consist of: left or right shunt,  ostium primum 
persistence, patency of the interventricular septum, mitral valve disease and tricuspid , 
interventricular communication, persistence of Botallo duct, isolated septal communication, 
tetralogy of Fallot. Most of these heart conditions are corrected surgically in early childhood, 
with a very favorable prognosis.
The diagnosis of cardiovascular problems may occurs during prenatal screening tests and must  
be confirmed by early neonatal examinations. The early diagnosis allows to carry out a therapy in 
a short time. The diagnosis is made by means of echocardiography.
Vision disorders 
 Ocular alterations in Down Syndrome, play a central role in the clinical situation. The most 
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obvious abnormality is the appearance of the eyelid usually oblique and narrow laterally, 
sometimes associated with blefarocalasi, hypertelorism, eyelid ptosis and blepharophimosis. 
These aspects are associated, in most cases, to a vertical fold of skin between the inner corner of 
the eyelid and the back of the nose: the epicanthus.
The spotted iris is characteristic of Down Syndrome with a prevlence range between  38 to85%. 
The so-called Brushfield spots are slightly raised white areas on the surface steelhead usually 
collected in a concentric ring of the pupil to the union of the middle third to the outer third of the 
iris surface.This would be explained histologically by the fact that the area between the spots 
shows a number of stromal fibers below the average.These stains are present at birth and could be 
considered  a useful diagnostic sign.  Other vision disorders include strabismus (20–47%), 
nystagmus (11– 29%), congenital cataract (4–7%), acquired cataract (3–15%), blepharitis (7–
41%), refractive errors (43–70%) and glaucoma (0.7%). Keratoconus is rare in childhood but 
develops later in life in individuals with DS.27,36   An early visual screening is essential for 
prevention and detection of defects that can be treated. 
 Ear, nose and throat disorders 
Hearing didorders and otologic problems are common  in children with DS, and these problems  
are related to  developmental problems. Midface hypoplasia is  typical in children with DS and 
consists of abnormalities of the nasopharynx, abnormal Eustachian tube anatomy, abnormal tooth 
development and agenesis of the teeth. These mid-face problems are often associated with 
hypotonia and macroglossia  and  are responsible for chronic middle ear disease and chronic 
rhinorrhoea. 
 A variety of immune disorders makes DS patient prone to upper airway infections.4 Even mild 
hearing loss can affect intellectual growth and cognitive  development, and in consequence, it can 
affect  child’s articulation skills. Regular assessment of the hearing function is highly 
recommended. An early detection of chronic ear disease in children with DS, immediately after 
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birth, may improve hearing.15  Moreover , in addiction to hearing problems, children with DS 
show delayed speech abilities.21 Sleep-disordered breathing in children with Down syndrome is 
seen in half of the children with DS. The most common causes include macroglossia, 
glossoptosis, recurrent enlargement of the adenoid tonsils and enlarged lingual tonsils. 
Respiratory disorders 
Respiratory problems are responsible for the majority of the morbidity and hospital admissions in 
children with DS. Respiratory syncytial virus (RSV) is seen more frequently and is associated 
with a greater risk for hospitalization in children with DS.4,13 Recurrent wheeze is very common 
among children with DS (it is found in up to 36%) and is related to previous RSV infection and to 
other factors such as tracheamalacia.3,4 The clinical picture may mimic asthma but is not 
equivalent to asthma. These respiratory problems can in turn become exacerbated because of the 
existence of CVD with haemodynamic instability and as a result of hypotonia, both known 
characteristics of DS. Other causal factors include airway anomalies like tracheolaryngomalacia, 
pulmonary anatomical changes like pulmonary hypoplasia, and subpleural cysts. Subpleural cysts 
are common in individuals with DS (up to 36%).2 Furthermore, an association with abnormal 
lung growth and lung hypoplasia is found in children with DS.1 40
 Gastrointestinal tract disorders 
Congenital birth defects of the gastrointestinal tract are present in 4-10% of children with DS and 
play an important role in morbidity during the first year of life. These defects are esophageal 
atresia / trachea-esophageal fistula (0.3-0.8%), pyloric stenosis (0.3%), the duodenal stenosis / 
atresia (1-5%), Hirschsprung's disease (1-3 %) and anal stenosis / atresia (<1-4%). These defects 
are more common in the population DS, as 25-30% of all cases of duodenal defects are in 
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children with the disease DS.9  The majority of these abnormalities requires immediate surgery 
for the correction of anatomical damage. Particular attention should be given to the issue of 
meconium (within the first 24 hours of birth) and signs of bowel obstruction.These abnormalities 
of the gastrointestinal tract make difficult the feeding in the first years of life of children who are 
exposed to greater risk of suffocation due to obstruction of the upper  airways.
 Celiac disease (CD) is another DS-specific disorder and is seen in 5-7% of children with DS, a 
rate that is ten times higher than normal population screening.38 Is definitely recommended early 
diagnosis of CD in DS population, in order to start the treatment and prevention of CD 
complications as failure to thrive, anemia, osteoporosis and malignant tumors. The occurrence of 
prenatal an aberrant right subclavian artery (ARSA, lusoria artery) has substantially increased in 
patients with DS, where it is at a maximum of 19-36%. ARSA can cause problems with the 
passage of solid food through the esophagus and dysphagia. In addition, impaired oral motor 
function, gastro-oesophageal reflux disease or congenital diseases should be considered as a 
cause of feeding problems in children with DS. 9,22
Constipation is another important   problem in children with DS and is basically related  to  
hypotonia; essential to monitor the amount of calcium and vitamin D introduced with the diet, 
since, these patients have a reduced degree of bone density
Another very important issue with respect to nutritional aspects is represented by body weight 
control. Individuals with DS, in fact, have a reduced metabolic activity and this leads frequently 
to obesity. 21
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 Haemato-oncological and immunological disorders 
Trisomy 21 is also associated with many changes in cellular function at the level of the 
hematopoietic immune system. Although the incidence of infection has been considerably 
reduced thanks to  the introduction of vaccinations for various viral and bacterial pathogens,to the 
widespread use of antibiotics and to the improved  hygiene conditions, the immune system in SD 
patient is otherwise altered from both qualitative and quantity point of view. For this reason DS  
patient are exposed  to a higher risk of infection during the entire life . Some authors reported 
abnormal maturation of thymus function and impairment of T cells on the contrary other authors  
showed  that, although many immune cells are immature, the B lymphocyte count is normal or 
only slightly reduced.In Downs  patients an altered turnover of  polymorphonuclear (PMN) is 
frequently observed. Circulating PMN and  monocytes showed functional defects (i.e. reduced 
chemotaxis). More surprising, though quantitatively much less important, is the propensity of 
children with Down syndrome to develop acute leukemia, the most commonly acute 
megakaryoblastic (M7) leukemia, with a frequency twenty times higher than that in the normal 
population (39). This is often preceded by neonatal reaction leukemoid (transient 
myeloproliferative diseases), which could be a form of leukemia transient. Leukemia affects 
roughly one child every 200 Down, 10-15 times  more compared to the frequency with which it 
occurs in the disease normal population (32).Conversely, the risk of development of malignant 
solid tumors is rather low compared to the rest of the population. However, in these cases, 
children with Down syndrome appear to have a better prognosis and require less chemotherapy 
than children without DS. 
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Endocrine disorders 
Thyroid disorders have been reported in up to 28–40% of children with DS, and this percentages 
increase with age  up to 54%.10,15,28 Thyroid abnormalities in DS population  included 
congenital hypothyroidism (1.8–3.6%) , primary hypothyroidism, autoimmune (Hashimoto) 
thyreoiditis (0.3–1.4%),compensated hypothyroidism (25.3–32.9%) and hyperthyroidism 
(Graves’ disease) (0–2%). The most common causes of hypothyroidism are acquired 
autoimmune: the body starts producing antibodies against the thyroid. In some cases, despite the 
presence of autoantibodies, thyroid succeeds in produce a sufficient amount of thyroxine (T4) 
and the therapy is not necessary and frequent checks are required only. In others, however, it is 
necessary replacement therapy, is very simple and very effective. Very often detection (with a 
simple blood test) of anti-thyroid antibodies (anti-thyroglobulin, anti-peroxidase, anti-
microsomal) even years before clinical manifestations of autoimmune thyroiditis.The clinical 
manifestations are:growth retardation, reduction of muscle tone, constipation and  dry skin which 
can easily be underestimated because confused with characteristics of the syndrome.Due to this 
endocrine disorders Children with DS have their own  particular growth pattern and DS-specific 
growth curves.7 The follow-up of length and weight in children with DS should be part of the 
regular medical screening with care in order to avoid overweight. In fact because of the metabolic 
problem, their propensity to over-eating and the  lack of exercise parents have to constantly 
monitor the weight.21 
 Orthopedic disorders 
The motoric system of children with DS is characterized by ligamentous laxity, joint 
hypermobility and hypotonia presenting in a variety of ways.5,15 Craniocervical instability has 
been reported in 8% to 63% of children with DS; atlanto-axial instability (AAI) occurs in 10% to 
30%. The delayed recognition of this condition can cause irreversible damage of the spinal cord. 
The instability can occur at the atlanto-axial or occipital-cervical joint. The  atlanto-axial  laxity 
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can be associated with the presence of an abnormal amount of collagen in the ligament level 
sideways, which, in turn, can cause an abnormal motion between the segments that lead to 
instability. Standardized radiographs of the cervical spine, including the 'front to back, mouth 
open, are useful tools to identify this instability, which is diagnosed on the basis of  the increase 
of the atlanto-dental interval, (ADI),  of the cervical spine. The occipital-cervical instability is on 
the other hand  more difficult to diagnose with radiographic techniques due to the overlap of the 
bony structures at the base of the skull. 
Although scoliosis can occur in association with Down syndrome. Most cases of scoliosis in 
these patients is presumed to be of  toracogenica nature, since it occurs secondarily to a 
thoracotomy pre-cardiac surgery. Acquired hip dislocation occurs in about 30% of children with 
DS and requires special attention. Very common is the presence of the flat-valgus foot and 
pronounced pronation of the foot, causing a difficult walking.
Urinary tract disorders 
Children with DS have significantly more risk of urinary tract anomalies (UTAs) (3.2%) such as 
hydronephrosis, hydroureter, renal agenesis and hypospadias. The diagnosis is performed by 
means of ultrasound. Symptoms are not always easy to detect  and may be masked because 
voiding disturbances and delayed toilet training are usually interpreted as a consequence of 
delayed psychomotor development. 16 40
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Dermatologic problems 
Dermatologic diseases are often present and are especially troublesome in adolescents21  and 
included: vitiligo (1.9%), seborrhoeic eczema (8–36%), folliculitis (10.3–26%) and syringoma 
(12.3–39.2%) are more frequently seen in children with DS. Rare but DS-specific problems are 
elastosis perforans serpiginosa and milia-like idiopathic calcinosis cutis.18,23 A previously 
reported high prevalence of atopic dermatitis (AD) in up to 56.5% of children with DS is 
probably an overestimation, as more recent studies suggest a lower prevalence of 1.4–3%. This 
could be the result of new and different diagnostic criteria for AD. This observation also notes a 
lower allergy risk in children with DS, which is in concordance with the studies on allergic 
rhinitis.17,18,23 
Another very frequent cutaneous manifestation in patients with DS is alopecia, a condition 
characterized by irregular hair loss presumably due to an impaired immune response the hair 
follicles. This "disease" occurs in patients with  DS with a frequency ranging from 5% to 9%, 
against a percentage that in normal population ranges between  l% and 2%. The hair loss may 
being either permanent or temporary and can occur simultaneously on more areas of the scalp.
	  Neuro-behavioral disorders 
 In DS patients  the IQ values vary, usually ranging from 35 to 70, indicating mild to moderate 
mental impairment; severe mental impairment is only occasionally seen in children with DS.8 
Counterproductive behaviour and avoidance tactics can impede learning, and language 
production is often substantially impaired. .15,21 Furthermore, impaired oral motor function can 
influence articulation. The SNC suffers the effects of the trisomic state for life. Except of a 
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certain degree of hypoplasia of the cerebellum , the brains of subjects suffering from SD is 
grossly normal. Except central hypotonia, which is perhaps the most frequent sign of SD, 
individual development is characterized by delay in cognitive development in early childhood, 
which is translates, in childhood, in a mild or moderate mental retardation, followed by the loss 
of cognitive skills in adulthood and the development of Alzheimer's disease (AD) in the 
following years. In fact, the deposition of the amyloid protein it has been observed  in the second 
decade of life in the affected subjects. The manifestation of  the complete pathology AD seems to 
be getting this for ages 35 years and older - a fifty years earlier than the normal population.21
Children with DS have more pronounced neurobehavioral and psychiatric problems, found in 
18% to 38%. The most frequent problems are disruptive behavior disorders, such as attention 
deficit hyperactivity disorder (6.1%), conduct/oppositional disorder (5.4%) or aggressive 
behavior (6.5%), and obsessive–compulsive disorders. More than 25% of adults with DS have a 
psychiatric disorder, most frequently a major depressive disorder (6.1%) or aggressive behavior 
(6.1%).15,21 40A diagnosis of autism or autism spectrum disorders in children with DS is found 
in 7%. This diagnosis is not easily made in children with DS mainly because of the resemblance 
and overlap of DS-specific behaviors and autism. 
Epilepsy is seen in 8% of children with DS, with 40% occurring in infancy and often presenting 
as infantile spasms.40
 Education and school 
Early intervention education systems are programs that can be used from the first months of life 
and provide tools to stimulate the development of children with DS, especially in the preschool 
period. Children with DS often begin primary school with extra support; successful outcomes are 
mainly in the area of social skills as a result of the ability to copy and mirror behavior. The 
outcome for adult social independence depends largely on the development of abilities to 
complete tasks without assistance, the willingness to separate emotionally from parents and 
access to personal recreational activities.21 40
15
 CONCLUSION AND RECOMMENDATIONS 
The Down syndrome is a complex pathology and associated with a number of systemic diseases 
with different level of severity. Mental retardation is always present, but often mild. Patients with 
DS should be monitored from birth for systemic diseases and to enhance and improve as much as 
possible the development and cognitive abilities. Life expectancy has increased considerably 
compared to the past and thus the effects of this age-old disease must be studied. Support for 
families is fundamental in helping patients with DS. [40]
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3. ORAL CAVITY ANOMALIES IN 
PATIENT WITH DOWN SYNDROME
Palate. The development of the mid face is less complete than that of the mandible. This 
incomplete development (midface complexis) results in reduction of the length, height, and depth 
of the palate, whereas the width is not markedly affected4,. Significant reduction in length gives 
the palate a "stair palate" appearance with high arch and occasionally palatal cleft-like folds are 
found. Also V-shaped high vault palates may show soft palate insufficiency4 and reduce the 
retention of maxillary dentures. Patients should be evaluated for orthodontic and surgical 
correction. 
Lips, oral opening, and covering mucosa. Hypotonia of the orbicularis muscle, the zygomatic 
arch, masseter and temporal muscles can result in several significant features. Characteristic 
facial appearance of SD is represented by  the lower lip hypotonic with tongue protrusion.
The lips are always slightly open because of the excessive size of the tongue which then 
protrudes from the outside of the oral cavity. This, associated with a typical xerostomia cause 
annoying angular cheilitis and dryness of mucous membranes.4,1
Tongue: patients with DS show numerous abnormalities of the tongue.
The tongeu is often hypotonic and protrudes. Macroglossia is not always true, but it is often 
apparent.
The problem seems to be in fact linked to a reduced size of the oral cavity instead of  a real  
excessive size of the tongue.
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The tongue due to an excessive pressure to the lower incisor present  the footprint of these 
elements on the  tip. These problem called  crenated tongue present a typical pattern shown as 
ovals depressed which are circumscribed by a white scalloped edge raised. This manifestation is 
always harmless and asymptomatic 5 .
Another feature is the presence of fissures of different lengths and depths on the dorsal surface of 
the front two-thirds of the tongue. In Down's syndrome can occur in combination with 
geographic tongue. These fissures can become impacted with food and cause halitosis. This can 
be controlled by regular brushing of the dorsal surface of the tongue. 5
Denatal anomalies in DS patients  included:
The microdontia affects 35-55% of SD. Dental elements are small than normal in both crown and 
root dimensions . Spitzer (1963) described them as "stunted with short, small crowns and roots." 
Kissling (1966) examined the diameters of the teeth and found that all the teeth, except for the 
first upper molars and lower incisors were reduced in size, but that the root formation was always 
root complete 6.
It can be assumed that the small size of the dental elements could be related to the  small body 
size that DS patients show respect to  the normal population.
Taurodontism: taurodontic teeth present with elongated pulp chambers and apical displacement in 
multi-rooted teeth . In DS it is common and the prevalence ranged from 0.54% to 5.6%. The most 
affected tooth is the second lower molar
Hypoplasia and / or hypocalcification are frequently observed. These abnormalities may be 
caused either by congenital malformations or by the use of tetracyclines in 'childhood for the 
treatment of infections. With this kind of dental anomalies we recommend a treatment that may 
include sealing or professional fluoride applications to prevent the worsening of the situation.
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These anomalies of form, size and calcification can all relate to each other and may result in a 
decrease in mitotic activity of dental progenitor cells during embryogenesis. 11
Partial anodontia. Congenitally missing teeth are more common among people with Down 
syndrome (50%) than the general population (2%), although the distribution of missing teeth is 
similar in both populations 6. the mode of genetic transmission are responsible for this condition. 
A relationship between partial anodontia and other ectodermal defects (mucosa, hair, skin) was 
suggested 4. Missing teeth more frequently in descending order are third molars, second 
premolars, lateral incisors and lower incisors.  The only teeth never missing is the first  molars 6. 
Sometimes the primary tooth will not be absorbed or will be absorbed so slowly that it can be 
maintained  in adulthood. 8
Tooth agenesis. Agenesis is 10 times more common in patients with Down syndrome than in the 
general population; there is a greater frequency in males and females, in the lower jaw  than in 
the upper jaw, and on the left side than on right. 12 The most affected tooth  are the lower central 
incisors, followed by upper lateral incisors, second premolars, and second lower premolar. 
Canines and first molars are rarely affected. Agenesis of canines and second molars was seen 
both in the maxilla and the mandible, where as the first molar agenesis was seen only in mandible 
12.
Dental caries. Low prevalence of dental caries in patients with Down syndrome is a favorable 
factor in the clinical management of these people. Orner's 13 study contrasts with dental caries 
experience of patients with Down syndrome with that of their sibilings; It found that patients with 
Down syndrome have experienced less than a third of caries than their unaffected siblings. 
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Shapira et al. 20 has found that adults with Down syndrome who  were caries free had 
significantly lower Streptococcus mutans counts than patients with dental caries. Several factors 
are considered responsible for the low prevalence of caries. Delayed eruption, reducing the time 
of exposure to a cariogenic environment, congenital missing teeth, higher salivary pH and 
bicarbonate levels (which provide better buffering action), microdontia, spaced teeth, and surface 
cracks of teeth contribute to this lower risk of dental caries. 14
Eruption of the primary dentition. Eruption of teeth is delayed in timing and sequencing, 
especially in the anterior maxillary and mandibular teeth and first molars. Central incisors erupt 
first and second molar usually last, but in the middle there is a large amount of variation in the 
sequence of eruption 8. The first eruption is usually at the age of 12 to 14 months, but may be 
delayed up to 24 months 8. By the time the primary dentition is completed the child may be from 
4 to 5 years of age.
Eruption of the permanent dentition. As the primary dentition, first eruption in permanent 
dentition is delayed. Six-year molars and lower incisors can not erupt until the age of 8-9 years 
15. The chronological sequence of eruption in Down syndrome is rather similar to that of the 
general population. 15
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Occlusion anomalies 
The following are oral manifestations related to occlusion and may require orthodontic or 
surgical intervention. 
Malalignment. A study by Ondarza et al.16 analyzed patients with Down syndrome and showed 
a higher frequency of malalignments in both the deciduous and permanent dentition compared 
with a group without Down syndrome. The most frequently involved teeth are central incisors, 
lateral incisors and canines. 
Malocclusion. The following factors play an important role in malocclusion: mouth breathing 
(96%), improper chewing (60%), evidence of bruxism (45%), tooth agenesis (12.7%), midline 
deviation in maxillary arch (80%), an anterior open bite (45%), dysfunction of temporo-
mandibular joint (24%), delayed eruption and exfoliation of both primary and secondary 
dentition, characteristic tongue thrust, hypotonic ligamentary apparatus of mandibular joint, 
developmental disturbances of the mandible (platybasia) and maxilla (mid-facial complex), and 
the jaw relationships. 
Jaw relationships. Several findings were reported by Kissiling (1966) in Down syndrome 
patients6. They are as follows: (1) mandibular overjet (69%); (2) anterior open bite (54%); (3) 
posterior cross bite (97%); (4) anterior cross bite (second largest category); (5) mesial molar 
occlusion (protruding mandible) (65%); (6) sagittal malocclusion (a result of relatively short 
maxilla and short middle cranial fossa). 
Midfacial complex. The midface in Down syndrome patients is more deficient than the 
mandible3. The anterior cross bites are attributed primarily to an anteroposterior deficiency of the 
maxillary arch rather than a constriction in the transverse dimension. This is further promoted by 
a lack of vertical development of the maxilla resulting in over closure of the mandible and 
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projecting the mandibular arch forward in relation to the maxilla. Because the mandible is not 
significantly affected, the apparent prognathism should be attributed primarily to the maxillary 
deficiency rather than to enlargement of the mandible3. 
Platybsia. Platybsia refers to the obtuse angle is formed by the anterior cranial base segment to 
the posterior cranial base segment to such a degree that it appears as a straight line, indicating a 
flat cranial base18. Failure of the occipital bone to grow down and back keeps the glenoid fossa 
high, which influences the position of the mandible to the glenoid fossa. Because there is a 
simultaneous maxillary deficiency, the mandible is not rotated3. Fisher- Brandies18 concluded 
that mandibular size starts at normal values but becomes mildly hypoplastic at age 14 and the 
gonial angle develops normally. From a longitudinal radiographic investigation, Reuland-Bosma 
and Dibbets19 found that the morphologic characteristics of the lower jaw are normal, but those 
of the symphysis are not. 
Bruxism. Bruxism is a common manifestation that starts early in life and sometimes persists 
throughout a person's life8. Initially bruxism eliminates some of the secondary and tertiary 
grooves and fissures found in newly erupted teeth. Over time, however, bruxism can lead to 
overloading the supporting tissue and its subsequent breakdown. In young children, "transitory" 
brux- ism is not uncommon8. In the preschool age child, bruxism rarely requires any active 
treatment. For active treatment a "mouth guard" type appliance may be used. The nature of the 
appliance will depend on individual needs. The appliance may not break the habit but rather 
protects the teeth. It redirects the child and thereby dismpts this self-stimulation activity8.
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Obstructive sleep apnea : people with trisomy 21 for their facial characteristics and for their   
functional impairement such as:
-relatively low muscle tone
- narrow nasopharynx
- wide and hypotonic tongue
and for their tendency to obesity and to develop recurrent infections at the level tonsil, are more 
likely than the general population to present sleep apnea  or obstructive airway disease .
The estimated incidence of central causes of sleep apnea in DS patient is very high
(89% of cases), while the Obstructive Sleep Apnea (OSA) has a variable frequency from 30 to 
60%. OSAS is a disease characterized by repeated episodes of complete or partial obstruction of 
the upper airway during sleep, usually associated with a reduction of the saturation of oxygen in 
the blood . Surgery, tonsillectomy and adenoidectomy, it is often the first choice of treatment, but 
in 30-50% subjects the problem persists despite intervention.
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4. PERIODONTITIS IN DOWN 
SYNDROME PATIENTS
The incidence of T21 is one in 800 to 1,000 live births in the United States. Generally, these 
patients now live to age 50 and some to age 60. As life expectancy increases, medical and social 
costs garner greater attention. Also, societal changes have allowed for better quality of life. 
Dental practitioners are challenged by the high incidence of early onset aggressive periodontal 
disease in T21; these patients have higher levels of periodontal pathogens and periodontitis-
associated interproximal bone loss. The complex anatomy, physiology, immunology, and 
microbiology underscore the need for further investigation in specific areas related to dental 
treatment of these patients.  
International literature11,12,13 showed how patients with Down syndrome (DS) are affected by a 
high incidence of gingivitis and periodontal disease, compared to the general population. The 
high prevalence and severe destruction are because of altered genetic factors that predispose to 
disease and poor skills to perform hygiene procedures11,12,13. For individuals with DS who 
lived in institutions, a periodontal prevalence of 90% was observed in individuals aged between 1 
and 39, whereas 36% of DS children with less then 6 years of age had periodontal pocket 
formation1. Orner2 observed that the periodontal disease in DS population occurred early and is 
characterized by a highly aggressive and severe destruction of the periodontal attachment with 
higher prevalence (89%) compared to their age-matched and chromosomally normal siblings 
(58%). Periodontal disease is considered to be a multifactor disease in which both endogenous 
factors, such as genetics and host immune response, and exogenous factors, such as oral hygiene 
contribute to the occurrence of the disease3. In patients with DS, oral home hygiene can be 
affected by poor compliance due to hands incoordination, insufficient motivation and difficulty 
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on the part of the caregiver in performing effective oral hygiene with classical devices4. 
However, the higher prevalence and severity of periodontal disease, which cannot be explained 
by poor oral hygiene alone is related to changes in the immune response. Swallow5 found that in 
DS patients the prevalence of periodontitis was higher in comparison to mentally retarded 
patients in three different environments: institutions, day training centers, and special schools. 
Although there were no differences in socioeconomic status, personal/professional dental care, or 
mental disability,6  the clinical attachment loss was found to be greater in DS patients than in 
mental retarded patients and control individuals (p<0.001). According to these findings several 
studies have suggested that abnormalities in the immune response of DS patients are important 
contributing factors to the high incidence of periodontal disease. Reduced expression of IL-10 
coupled with a possible increase of STAT3 activation indicates an important modulation of the 
immune response, with attenuation of anti-inflammatory and increase of pro-inflammatory 
mediators7.
Subjects with DS and gingivitis exhibit higher concentrations of MMPs in gingival crevicular 
fluid and an altered relationship between MMP-8 and TIMP-2, which might impair the 
periodontal tissue turnover8.
Oxidative burst activity of peripheral monocytes and granulocytes is elevated in DS affected 
individuals and may contribute to periodontal tissue inflammation and loss of periodontal 
attachment in this susceptible group9.
The use of simple techniques and chemical antibacterial agents could be an important aid to 
mechanical procedure, in order to prevent the occurrence of periodontal disease10. 
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Periodontal treatment in Down syndrome patients.
While healthcare professionals may be familiar with the social and medical management of 
Down syndrome, dental issues have traditionally been somewhat neglected and are important 
causes of morbidity. 
Periodontal disease has been found to be significantly more prevalent and more severe in people 
with Down syndrome. A series of studies have reported a prevalence of between 58% and 96% 
for persons younger than 35 years of age. This phenomenon cannot simply be attributed to poor 
oral hygiene. The etiology of periodontal disease in persons with Down syndrome is complex. In 
recent years, much focus has been placed on the altered immune response resulting from the 
underlying genetic disorder. 17
Increased loss of periodontal attachment in patients with Down Syndrome was not associated 
with differences in socioeconomic status, personal or professional dental care, or mental 
retardation. These data are consistent with the conclusion that the pathogenesis of periodontitis in 
patients with Down Syndrome is not governed by the known risk factors of periodontitis in the 
general population19. 
Underlying immunologic deficiencies associated with Down syndrome, including decreased 
neutrophil chemotaxis, contribute to a diminished host response that accounts for the severity and 
progression of periodontitis21.These individuals may already have physiological limitations for 
efficient swallowing and mastication.Painful and inflamed oral tissues associated with 
periodontitis can exacerbate this, making it difficult to achieve appropriate caloric intake and 
perform oral hygiene practices, ultimately diminishing quality of life20.Subjects with Down 
syndrome  experience a high prevalence of periodontal disease, and the management of this 
disease in subjects with Down Syndrome is a challenge for oral health care providers.
Ronald et al. 15 followed the periodontal healing response changes over a 12-month period after 
non-surgical mechanical periodontal therapy with the adjunctive use of chlorhexidine and 
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monthly recalls in adults with DS who presented initially with chronic periodontitis. Following 
their protocol, satisfactory healing responses were achieved in adults with DS with chronic 
periodontitis and mild-to-moderate learning, decreasing the number of sites with bleeding on 
probing decreased from 82.1% to 29.5% and the mean probing depth from 3.2 to 1.8 mm, with a 
mean clinical attachment level gain of 0.6 mm15.
In a pilot study Tanaka et al. 14 found  that, although the mechanical periodontal treatment 
seemed to be effective in DS subjects over a short-term period, the red complex bacteria levels 
did not decrease significantly in dis- eased sites, as occurred in controls. Therefore, for DS 
patients, it seems that the conventional non-surgical periodontal therapy should be improved by 
utilizing adjuvants to reduce the presence of periodontopathogens. 
Zaldivar-Chiapa et Al. 16 evaluated the effectiveness of surgical and non-surgical periodontal 
therapies and analyzed immunological status in a population of young Down syndrome patients 
(14-30 years). Surgical and non-surgical periodontal therapies were compared in a split-mouth 
design. Both therapies showed a significant improvement in all the clinical parameters compared 
to baseline. There was a significant PD reduction with the non-surgical therapy at 1 to 3 mm PD, 
in PD >3 mm the surgical therapy showed better results. Neutrophil chemotaxis, phagocytic 
activity, and production of super-oxide anion were significantly decreased in the DS patients. 
There is partial impairment of immunological functions in DS individuals which does not seem to 
affect the clinical response to therapy16. 
Cheng RH et Al. 23 followed the periodontal healing response changes over a 12-month period 
after non-surgical mechanical periodontal therapy with the adjunctive use of chlorhexidine and 
monthly recalls in adults with DS who presented initially with chronic periodontitis. Twenty-one 
subjects with DS (14 males and seven females; 25.3 +/- 5.5 years of age) with reported mild-to-
moderate learning disabilities and chronic periodontitis were recruited and treated by non-
surgical mechanical periodontal therapy (followed by monthly recalls) and the adjunctive use of 
chlorhexidine gel for toothbrushing and chlorhexidine mouthwash twice daily.  After 12 months 
of non-surgical mechanical periodontal therapy, the mean percentage of sites with plaque 
decreased from 84.1% to 23.6%, bleeding on probing decreased from 82.1% to 29.5%, mean 
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probing depth decreased from 3.2 to 1.8 mm. Such a treatment regimen seems appropriate and 
beneficial for adults with Down Syndrome and chronic periodontitis.
Yoshihara T et al. 18 examine the effect of periodic preventive care on the progression of 
periodontal disease in 24 young adults with Down’s syndrome dividing into two groups: 13 
subjects who had frequently had professional tooth cleaning, various combinations of scaling, 
and counseling for caregivers regarding caries and periodontal disease and 11 subjects who had 
not visited our clinic for more than 1 year. The progression of periodontal disease in the subjects 
was evaluated clinically, microbiologically and roentgenologically. The results of this study show 
that individualized preventive dental care, performed regularly using generally available methods 
and maintaining adequate oral hygiene, are effective for suppressing the severity and progression 
of periodontal diseases in DS patients. 
Treatment recommendations range from conservative to aggressive regimens, depending on the 
severity of the presentation. It is known that some periodontal pathogens may not be eliminated 
solely by mechanical debridement; therefore, antibiotics and chemical therapeutics often serve an 
important role in achieving successful outcomes22.
Therapeutic protocols should include behavioral and social aspects for pediatric Down Syndrome 
patients. This would assist providers in making timely management decisions and facilitate 
diagnosis and management of periodontal diseases in this cohort. Though the approach to care 
should be carefully individualized.
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5. NON SURGICAL PERIODONTAL 
THERAPY
 
Control of sub-gingival bacterial plaque
Root planing has been shown to cause a transient change in the composition of the subgingival 
plaque. Studies have demonstrated the change through a reduction of Gram- bacterial species and 
a concomitant increase of gram-positive bacterial species that are associated with gingival health 
condition. (Listgarten et al. 1978 Sbordone et al. 1990 Haffajee et al. 1997a, Stelzel & Flore`s-de-
Jacoby 2000 Chaves et al. 2000). Recently, Haffajee et al. (1997a, b) and Cousins et al. (2000) 
reported that scaling and root planing resulted in significant decreases in the counts of DNA 
probes of a specific subset of microbes subgingival, including Porphyromonas gingivalis, 
Treponema forsythus Bacteroides and denticola. In conjunction with decreases in this subgroup 
of bacteria were significant increases Actinomyces sp., Capnocytophaga sp., Fusobacterium 
nucleatum subsp. polymorphum, Streptococcus mitis, and Veillonella parvula. Results similar 
projection decreased levels of P. gingivalis and T. denticola were reported by Ali et al. (1992), 
Simonson et al. (1992), Shiloah and Patters (1994), and Lowenguth et al. (1995). Although 
spirochetes, microbes motility and Bacteroides sp. are regularly reduced in numbers after scaling 
and root planing, other species appear to be more resistant, such as Actinobacillus 
actinomycetemcomitans and P. gingivalis (Siloam & Patters 1994 Troil von-Linde 'n et al., 1996 
Haffajee et al. 1997a).
Some bacteria have proven to be more difficult to eradicate. In particular, A. 
actinomycetemcomitans, P. gingivalis. The difficulty in the eradication is in part explained by the 
A.A. ability to invade the epithelium and periodontal tissues (Sato et al., 1993 Mombelli et al. 
2000). Surviving protected from the tissues in which they are penetrated these bacteria may 
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represent the "reservoir"  that can trigger a relapse after periodontal therapy. (Slot & Rosling 
1983 Christersson et al. 1985 Shiloah 1994 Mombelli 1994) These bacteria are in fact associated 
with the lack of positive response to periodontal treatment. Patients so-called  "refractory" in fact 
show the persistence of bacteria such as AA and Pg even after therapy (Daly et al., 1982 Adriaens 
et al., 1988, Giuliana et al. 1997).
To obtain stable changes in the bacterial flora of the oral cavity it is seen that it is necessary that 
there is an optimal control of supragingival bacterial plaque. Also there are some niches of the 
oral cavity which are areas of accumulation of bacterial species that can re-colonize the pockets 
and cause a relapse. These niches are represented by the tongue and tonsils. Some studies have 
taken into account during the causal therapy  with appropriate treatment  the back of the tongue 
and irrigation with chlorexidina to eliminate bacteria from these niches.The supportive 
periodontal treatment  aims to control supra gingival plaque accumulation (Westfelt et al., 1983 
Lindhe & Nyman 1984 Harper & Robinson 1987 van Winkelhoff et al. 1988 Renvert et al. 1990a, 
Shiloah and Patters 1996, Cobb et al 2002)
Removal of sub-gingival calculus
“The concept of removing all sub-gingival calculus and contaminated cementum has been shown 
to be unrealistic and quite likely unnecessary”(Borghetti et al. 1987, Breininger et al. 1987, 
Eschler & Rapley 1991, Fukazawa & Nishimura 1994).The complete calculus removal not only 
seems to be unrealistic, but also unnecessary. It has been seen that the presence of tartar remnants 
on the root surface are compatible with the obtaining of a state of gingival health. (Nyman et al. 
1986 Bloemhof et al., 1987 Buchanan & Robertson 1987)
Even the intentional removal of the root cement is today to view in a different manner. Previously 
it was believed necessary to remove the root cementum because it was believed that the LPS 
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were closely connected to the root surface. But today we know that there is a weak link and that 
the cementum should not be instrumented excessively. Numerous studies have demonstrated that 
the sonic and ultrasonic instrumentation lead to similar results to those obtained with hand 
instruments. (Badersten et al. 1981, 1984a, 1984b, Nyman et al. 1986 Checchi & Pelliccioni 1988 
Cheetham et al., 1988, Smart et al., 1990 Chiew et al. 1991 1990 Copulos Laurell et al. 1993)  . 
(Cobb C.M. 2002)
Manual and sonic/ultrasonic instrumentation 
Numerous studies have shown comparable efficacy between the manual and the ultrasonic 
instrumentation in terms of calculus removal  and consequent improvement in clinical parameters 
of periodontal disease. The ultrasonic instrumentation, however, seems to be equally effective in 
less time, with a saving of time which seems to be between 20-50% (Badersten et al. 1981, 
1984a, 1985a, Loos et al. 1987, 1989, Checchi & Pelliccioni 1988, Kawanami et al. 1988, Laurell 
& Pettersson 1988, Laurell 1990, Dragoo 1992, Copulos et al. 1993, Grant et al. 1993, Boretti et 
al. 1995, Drisko 1995, Kocher et al. 1997, Yukna et al. 1997Checchi&Pelliccioni 1988, Dragoo 
1992, Copulos et al. 1993, Drisko 1995).
The complete calculus removal  is closely linked to the  root surface morphology/anatomy  and to 
the pockets depth. Obviously PPD increases with increasing the proportion of non removed 
calculus (Waerhaug 1978a, 1978b). In fact, Stambaugh et al. (1981) noted that the removal of all 
plaque and subgingival calculus was unlikely to occur when the average probing pocket depth  
were 3.73 mm. In particular 2 studies have been conducted in order to compare the efficacy of 
ultrasonic instruments with standard tips versus ultrasonic instruments with very thin tips. The 
results were controversial  because according to the study of Dragoo 1992 is not possible with 
any type of tip reach the bottom of deep pockets, while according to Clifford et al. (1999) both of 
the ultrasonic tip types were able to reach the bottom of the examined periodontal pockets.
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Although studies in the literature report these partial effectiveness of etiological therapy since no 
instrument has proved to be  completely able to  remove all the etiological agents, the etiological 
treatment was demonstrated  to be effective in the control of periodontal disease in the short and 
long term. This can be explained through the concept of 'critical mass' (WWP 1989). "As applied 
to non-surgical periodontal therapy, the concept of critical mass is becoming better understood 
that a major goal of periodontal therapy is to reduce the amount (mass) of bacterial plaque to a 
level (critical) that results in a balance between the residual microbes and the host response, that 
is, no clinical disease. Given the physical limitations, both anatomical and instrumental, of 
subgingival scale and / or root planing, it can be argued that it is extravagant to suppose that 
doctors can remove all subgingival plaque and tartar ”.(Cobb C.M. 2002)
Root surface smoothness
The importance of obtaining a smooth root surface has been a controversial topic for a long time. 
In the past it was believed that the root surface should be smooth in order to be biocompatible 
and to obtain a  state of health. This idea was born from the studies conducted earlier by 
Waerhaug (1956) on experimental animals and later by other authors (Keenan et al. 1980 Budtz-
Jorgensen & Kaaber 1986 Quirynen & Listgarten 1990 Leknes et al. 1996) which showed an 
association between the root surface roughness and plaque accumulation. According to these 
authors the  smoothness of the root surfaces obtained by root planing  allowed to have 
biocompatible  surfaces and to  improve clinical parameters. Conversely Rosenberg & Ash 
(1974) and subsequently Khatiblou & Ghodssi (1983) and Oberholzer & Rateitschak (1996) 
found no correlation between the presence of smooth root surfaces and periodontal health status.
According to the studies of Quirynen et al., 1993 and Bollen et al. 1996a surfaces with a 
roughness greater than the 0.2 mm threshold are associated with an increase in the retention of 
bacterial plaque.
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An important in vitro study by Schlageter et al. (1996) has allowed to obtain a scale of roughness 
of root surfaces produced with the use of different and manual and  rotating and / or sonic and 
ultrasonic instruments. The surprising result was that independent of the instrument is not 
possible to obtain  a root surface with a roughness value of less than 1.6 mm. This means that at 
present with the available instruments we are not able in any way to make the root surface 
smooth enough to reduce bacterial colonization. In other words  we can say that obtain a smooth 
root surface is an unrealistic goal of the periodontal therapy.
Nonsurgical therapy 
The objective of non-surgical periodontal therapy is to remove by means of manual and 
ultrasonic instruments  the supra and the  subgingival calculus. The calculus elimination causes a 
change in the composition of bacterial plaque and a consequent improvement in clinical 
parameters and in the reduction of  the inflammation signs. This, as we have already said, is 
compatible with the presence of a certain amount of calculus residual and is independent of the 
type of instrument used.
The root planing leads to good results even if  there are some factors limiting the desired gingival  
health status . The percentage of residual calculus after root planing ranges  from 3% to 80% 
depending on the root surface considered. (Mongardini et al 1999)
In particular it is seen that the deep pockets and the  furcation defects  represent  areas of difficult 
access for the instruments, and then are areas with the greatest risk of persistence of clinical signs 
of inflammation. One study (Wylam 1983) evaluated the instrumentation of compromised molar 
furcations with an open flap approach versus a  closed non surgical treatment  and found that  in 
both groups the use of motor instruments has been proven to be more effective in terms of 
calculus elimination . Today on the market are available  ultrasonic tips with very small 
dimensions designed to get into the small area of access of bifurcations.
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The result of non-surgical periodontal therapy has also proved closely related to the skill and 
experience of the operator. (Kocher et al 1997).
Even the over-instrumentation of root surfaces obtained with numerous and vigorous curettes 
strokes has proven useless and harmful. An over-instrumentation can indeed lead to excessive 
dentine hypersensitivity very troublesome for the patient even up to cause pulpitis (Fukazawa 
1994)
The objective of  non-surgical periodontal therapy  is to obtain a clinical attachment gain through 
a  probing pocket depth  reduction  and an increase of the gingival  recession. Several studies  
showed that in  presence of pockets depth between 4-6 mm, root planing is effective both in term 
of PPD reduction and in term of CAL gain. In presence of pockets with more than 7 mm depth 
we obtained  a reduction of PPD and a significant CAL gain. The pocket closure and the clinical 
attachment gain is proportional to the initial probing pocket depth. Otherwise the sites with a 
probing depth of between 1 and 3 mm showed attachment loss when subjected to root planing 
and therefore should be treated only with scaling. (Knoweles 1979 ,1996 Pihlstrom 1983 Becker 
2001).Teeth  with furcations involvement showed a worse prognosis than single-rooted elements 
after periodontal treatment (Kalkwarf 1988).
To obtain significantly positive results with non-surgical therapy is necessary, in addition to 
subgingival instrumentation, achieve optimum supragingival plaque control. In fact, in presence 
of lack of oral hygiene, the transitional change in the subgingival microbiota,induced by the 
disruption of the biofilm, is lost in a short time and we observed the  recurrence of a periodontal 
pathogenic bacterial flora.
 Studies conducted by Badersten have shown that it is possible to obtain thanks to the  
periodontal treatment (i.e.scaling and root planing) associated with optimal level of  oral hygiene 
a reduction in bleeding index <20% regardless of the initial depth of the pocket. These results can 
be successfully maintained  stable in the next 2 years.
Non surgical therapy can be accomplished by different kind of instruments: hand instruments, 
sonic/ultrasonic instrument e rotary instruments.
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Hand instrument are basically the curettes: Universal curettes with 2 working parts for each side 
or Gracey curettes with only one cutting part for side. The dimension of the blade could be 
standard or mini. 
Sonic scalers use air pressure to create mechanical vibration.
Ultrasonic instruments can be piezoelectric or magnetostrictive. The piezoelectric scaler vibration 
is linear while the magnetostrictive is elliptical.
Fine grained diamond burs can be used for root planing usually during open flap curettage.
The re-evaluation after cause related therapy is performed after 3 months. This period correspond 
to the  connective tissue healing period. Measurements performed at baseline( before treatment) 
and after therapy, at least after 3 months are:-­‐ plaque index-­‐ bleeding score-­‐ PPD probing pocket depth( distance between gingival margin and the tip of the probe inside the 
sulcus/pocket)
-REC gingival recession ( distance between most apical extension of the gingival margin and the 
CEJ)
CAL clinical attachment level ( PPD+REC)
All these  data have to be collected in a periodontal chart. Patients have to be carefully instructed 
to oral hygiene procedures. Patients have to be instructed and motivated because without patient 
compliance we can not expect a good final result.   
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 Different approaches for non surgical therapy
 Traditionally root debridement is performed in a quadrant-by-quadrant approach. The protocol 
consist of four weekly one hour root planning sessions with manual and ultrasonic devices under 
local anesthesia. This approach offers the advantage of being able to check the patient oral 
hygiene procedure and to reinforce instruction and motivation every week for one month.
Bollen et al. , Mongardini et al. , Quirynen et al.  studied the hypothesis that plaque control and 
root debridement might be enhanced by a concomitant  full mouth disinfection . This initially 
involved scaling and root planing of all quadrants within 24 h in combination with the application 
of chlorhexidine to all intraoral niches for 2 months both in the dental surgery and at home. 
Compared to a conventional, quadrant-by-quadrant approach to nonsurgical treatment, clinical 
and microbiologic parameters showed improved results following periodontal debridement 
completed within 24 h combined with simultaneous and postoperative full-mouth disinfection. 
These results confirm those of a similar study by Bollen et al.  The findings suggest that re-
infection of treated sites during the healing phase may occur from remaining untreated sites, or 
from other niches in the oral cavity. Quirynen et al., studied the relative importance of the use of 
chlorhexidine in the full-mouth disinfection. Clinical and microbiologic results from the studies 
indicated that chlorhexidine had no adjunctive effects. However, its use may be advisable in 
patients with a low compliance and because it aids initial healing.Another consideration in 
relation to non-surgically performed SRP is the extent of root instrumentation required for 
periodontal healing. The original intention with SRP was not only to remove microbial biofilm 
and calculus but also ‘‘contaminated’’ root cementum or dentin in order to prepare a root surface 
biocompatible for soft-tissue healing. The rationale for performing root planing was based on the 
concept that bacterial endotoxins penetrate into the cementum ( Aleo et al. 1974), a concept that 
was later disproved by data from experimental studies showing that the endotoxins were loosely 
adhering to the surface of the root cementum and not penetrating into it .Hence, intentional 
removal of tooth structures by root planing during pocket/root instrumentation may not be 
considered as a prerequisite for periodontal healing (Nyman et al. 1986, 1988). Consequently, 
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pocket/root instrumentation should preferably be carried out with instruments that cause minimal 
root substance removal, but are effective in disrupting the biofilm and removing calculus. In this 
respect, data reported in studies that evaluated root substance removal following the use of 
various manual and power-driven instruments  encourage the use of ultrasonic devices. This is 
the rationale of the full mouth ultrasonic debridement proposed by Wennstrom et al 2005  
consisting  of a single one hour ultrasonic session of full mouth sub gingival debridement.
This approach has been demonstrated to be effective as the traditional one but in a shorter chair-
time e with less discomfort for the patient. 
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6. EXPERIMENTAL PROCEDURE
The aim of this study was to evaluate the clinical efficacy of a single session of full-mouth 
ultrasonic debridement (Fm-UD) as an initial periodontal treatment approach in comparison with 
the traditional treatment modality of consecutive sessions of Q-SRP in patient with DS.
MATERIALS AND METHODS
Study design
The trial was designed as a randomized, controlled, single-masked and parallel group study of 6 
months duration, and was conducted at the ” Servizio di Assistenza Odontoiatrica per Disabili” at 
the  DIBINEM (UNIBO) from January 2013 to December 2015. Approval of the study protocol 
by the Local Ethics Committee  was obtained, and all caregivers of the  participating subjects 
received informed consent before the start of the study.
Patient sample
Forty  patients, 20 patients for each group , with moderately advanced chronic periodontitis, were 
recruited for the study following a screening examination including full-mouth probing
and radiographic evaluation. The following criteria were used in the selection of study subjects:
Inclusion criteria
 -down syndrome patients
 -Age 15-35 years;
-A minimum of 18 teeth;
- At least eight teeth must show probing pocket depths (PPD) of  ≥ 5 mm and bleeding on probing 
(BOP). 
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Exclusion criteria
-Sub gingival instrumentation within 12 months prior to the baseline
examination;
- Ongoing drug therapy that might affect the clinical signs and symptoms of periodontitis.
Sample size
Power calculation based on the detection of a difference in the mean PPD reduction of 0.5mm 
between treatment groups, assuming that the common standard deviation (SD) is 0.6 mm, and
with an ∝ error defined to 0.05 and β error defined to 0.20, revealed that 20 subjects in each 
treatment group were required.
Examinations
Full-mouth clinical examinations were performed immediately before treatment (baseline)  and 6 
months following the completion of the baseline treatment protocol. All teeth and tooth sites, 
(except third molars) were included in the examinations.
The following variables were recorded at 4 aspect of each tooth (mesial, buccal, distal
and lingual surfaces of each tooth):
-Plaque score (PS): presence/absence of plaque at the cervical part of the tooth scored by running 
a probe along the tooth surface.-­‐ Bleeding on probing (BoP): presence/absence of bleeding within 15 s following pocket probing.
- Probing pocket depth (PPD): measured with a manual Hu– Friedy PCP 15 periodontal probe to 
the closest lower millimeter.
-Recession (REC): the distance between the GM and a fixed reference point on the tooth 
(cemento- enamel junction (CEJ) 
-Clinical  attachment level (CAL) was calculated as PPD+REC.
Furthermore  the  number of anesthetic’s cartridges used for each patient was collected. 
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One examiner (a periodontist), who was masked with respect to the treatment assignments, 
performed all examinations.Before the study, the examiner was calibrated to reduce 
intraexaminer error (k>0.75) to establish reliability and consistency.
Randomization
A random assignment to the two treatment protocols  was subsequently performed by the use of 
computer-generated tables.  Based on the randomization procedure, 20 patients were assigned to 
the test treatment and 20  to the control treatment.Allocation concealment was achieved using a 
sealed coded opaque envelope containing the treatment of the specific subject. The sealed 
envelope containing treatment assignment was opened immediately before treatment.
FMUD–test
The patients assigned to this treatment group received, at baseline (Day 0), a 1-h session of full-
mouth subgingival debridement using a piezoceramic ultrasonic instrument (EMS Piezon Master
400 with A and  P perio tips, water coolant and power setting to 85%; EMS).
Q-SRP – control
The patients in the SRP group were subjected to quadrant Scaling and Root Planing  at four 
sessions with an interval of 1 week. An assortment of manual periodontal Gracey curettes was 
used (LM-dental number 7/8, 11/12, 13/14). 
For both treatment protocols, local analgesia was used if requested by the patient. The same 
expert periodontist  who was  trained with regard to the various procedures included before the 
start of the study, carried out the treatment.
All patients received oral hygiene instructions immediately prior the starting of the 1-h session of 
FMUD in the test group and immediately prior the starting of the first session in the control 
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group. Therefore patients underwent to monthly plaque control sessions and oral hygiene 
reinforcement. Patients and/or  caregivers were instructed to use chlorhexidine toothpaste  twice a 
day after  non-surgical periodontal therapy for 6 months.
Fig 1.Flow chart of the study design
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Statistycal analysis 
Descriptive statistics were expressed as mean (SD). Student’s t-test was used to evaluate 
differences between baseline and 6 months follow-up and between groups regarding PD,
CAL, REC, PI and BoP. ANOVA for repeated measurements was used to test interaction between 
treatment and time.
Statistical analysis was performed with Stata  (Stata , version 13.0; Statacorp LP, College Station, 
TX, USA).
In all tests a significance level of 0.05 was chosen.
The descriptive statistics for the clinical parameters measured at baseline and 6 months  after 
therapy  for both groups are shown in Table 1
Results
PPD: significant (p < 0.0001) decreases were observed in both groups at 6 months compared to 
the baseline measurements,while no between groups significant differences were found and no 
interaction effect between time and treatments (Fig 2 and Fig 2a)
REC: significant (p < 0.0001) increases were observed in both groups at 6 months compared to 
the baseline measurements,while no between groups significant differences were found and no 
interaction effect between time and treatments (Fig 3 and Fig 3a)
CAL: significant (p < 0.0001) decreases were observed in both groups at 6 months compared to 
the baseline measurements,while no between groups significant differences were found  and no 
interaction effect between time and treatments (Fig 4 and Fig 4a)
PI:  significant (p value < 0.0001) effect for time and  for treatment (p value =0.0264) 
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 ( or group) and no interaction effect between time and treatments (Fig 5 and Fig 5a)
BoP: significant (p value < 0.0001) effect for time and  for treatment (p value =0.0264)  ( or 
group) and no interaction effect between time and treatments (Fig 6 and Fig 6a)
Treatment discomfort
None of the patients experienced acute problems (e.g. periodontal abscesses) during the study 
period. In the test group the mean number of anesthetic’s cartridges used during the FMUD 
session was 1,2 while in the control group was 4,5.
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TEST CONTROL
PPD
baseline 6± 0,45 5,98± 0,57
6 months 4,16± 0,66 4,36±0,72
REC
baseline 1,33± 0,55 1,18± 0,46
6 months 1,92± 0,41 1,75± 0,38
CAL
baseline 7,34± 0,69 7,16± 0,57
6 months 6,11± 0,57 6,1± 0,67
PI
baseline 84,55± 10,22 86,1± 9,37
6 months 28,85± 8,88 28,75± 8,64
BoP
baseline 82,75± 10,11 85,2± 8,33
6 months 23,05± 8,27 29,3± 8,46
Table 1: Descriptive statistics for the clinical parameters measured at baseline and 6 months
after therapy
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Fig 2: Box plots of PPD measurements for time and group
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Fig 2a : interaction plots on the PPD measurements means over time
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Fig 3: Box plots of REC measurements for time and group
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Fig 3 a: interaction plots on the REC measurements means over time
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Fig 4: Box plots of CAL measurements for time and group
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Fig 4a: Interaction plots on the  CAL measurements means over time
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Fig 5: Box plots of PI measurements for time and group
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Fig 5a: Interaction plots on the PI measurements means over time
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Fig 6: Box plots of BoP measurements for time and group
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Fig 6a: Interaction plots on the BoP measurements means over time
83
Discussion
The present study demonstrated the efficacy of a single session of full-mouth ultrasonic 
debridement (Fm-UD) as an initial periodontal treatment in patient with DS and moderate-
advanced periodontitis. The efficacy was demonstrated using for outcome variables the reduction 
in bleeding on probing and in probing pocket depth which represent the clinical signs of the  
resolution of the inflammation. In the present study, the full-mouth mean percentage of sites with 
BOP was reduced from 82 to 23% in the test group and from 85 to 29% in the control group over 
the 6-months observation  period, which is a result similar to the one obtainable in periodontal 
patients without down syndrome.The mean PPD values at 6 month were 4.16 mm in the test 
group and 4.36 mm in the control group. 
The  single session of Fm-UD has already been demonstrated (by Wennstrom et al) to be 
effective in the  infection control in patients with chronic periodontitis and was able to provide  
clinical improvements that were not significantly different from those observed in a control group 
treated by Q-SRP. The results of our study performed on DS patients are fully  in agreement with  
those of  Wennstrom et al.
However, an important difference in the two studies is detectable. In the present trial in both 
groups at baseline the percentage of PI was very high in both treatment group:84% in  the test 
group  and 86% in the control one.
In the paper by Wennstrom et al performed on patients without disabilities with the same 
periodontal parameters for inclusion criteria, the baseline PS was in mean 22% in the control 
group and  23% in the test group. This significant difference could be related to the fact that in 
the present study patients and/or caregivers  were instructed and motivated for oral hygiene 
procedure during the first treatment session after the baseline measurements collection while 
patients in the other study were motivated before the treatment sessions and the PS was recorded 
3 weeks after the new oral hygiene instruction. The interesting findings of the present study was  
that after oral hygiene instruction in both study group patients were able to significantly  decrease 
PI and to reach and maintain for 6 months an acceptable level of plaque score: 28% in both 
groups. This value is somewhat higher than the ideal plaque score we would like to obtain in 
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periodontal patients which has been settled at a level < 25%. However in this kind of patients 
with  mental and manual disability represents an optimal result which is in agreement with a 
previous  prospective clinical study (Cheng et al.) on patients with DS evaluated  at 12 months, 
that showed a  mean percentage of sites with plaque decreasing  from 84.1% to 23.6%, and the 
mean percentage of sites with BOP decreasing  from 82.1% to 29.6%. 
In the present study patients in both treatment groups were instructed to use twice a day a 
chlorexidine toothpaste and were monthly recall. This very stringent recall program seems to be 
the key to success in these patients with poor collaboratives capabilities and these finding is in 
agreement with a recent case series .Cheng et al 2008 demonstrated that appropriate 
modifications to routine non-surgical periodontal therapy, with the twice-daily use of 
chlorhexidine and a monthly plaque control–focused recall schedule, could significantly improve 
patients’ periodontal conditions to levels comparable to those achieved with the non-surgical 
treatment of periodontitis in adults who did not have DS.
In literature very few randomized controlled clinical trial regarding periodontal treatment in DS 
patients are present. In a split-mouth design study in 14  DS patients, Zaldivar- Chiapa et al. 
reported at 1 year no significant differences between surgical  and non-surgical periodontal 
treatment approaches.  Conversely, another study ( Sakellari et al.), performed in only five 
subjects treated by non-surgical periodontal therapy showed insignificant treatment responses.
In this perspective a rapid treatment, which does not require long permanence to the chair, 
slightly painful and invasive, is certainly more indicated. The Fm-UD showed good clinical 
results in terms of infection reduction and associated with a stringent recall program and with the 
adjunctive use of chlorexidine could represent an optimal treatment choice in patient with DS and 
periodontal disease (Quyrinen et al ). Moreover this approach has proved to be easily applicable  
in this type of patients.Indeed, the use of ultrasonic instrument instead of sharp manual curettes is 
definitely more appropriate because if the patient is not fully collaborative during treatment 
sessions with manual instrument there is a risk of causing injury.
This approach was able to reduce burden for both patient and family as it requires a single session 
and a short chair-time with respect to the traditional 4 quadrant therapy. 
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Furthermore the  Fm-UD has proven to be a less invasive technique. The number of anesthetic 
cartridges used in the test group was significant lower than the control group which means that 
patient experience less pain with the proposed technique.
Conclusion
No statistically significant differences in terms of PPD reduction and BoP were observed between 
the proposed techniques and in both group patients obtained a significant improvement of 
periodontal health status. The Fm-UD from a patient’s perspective showed the best results 
limiting the chair-time and the discomfort.
Further studies with a larger sample size are advocated in order to confirm present data.
In future  this approach could be a viable therapeutic option for the treatment  of periodontal 
disease in patient with poor compliance. 
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